Standout Papers

Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials 2020 2026 2022 2024425
  1. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials (2020)
    Philippe Gevaert, Theodore A. Omachi et al. Journal of Allergy and Clinical Immunology

Immediate Impact

1 from Science/Nature 48 standout
Sub-graph 1 of 18

Citing Papers

Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma
2024 Standout
2 intermediate papers

Works of Kit Wong being referenced

Interleukin-13 in Asthma and Other Eosinophilic Disorders
2017

Author Peers

Author Last Decade Papers Cites
Kit Wong 418 450 364 9 673
Joke Patou 513 470 535 10 848
Monet Howard 330 394 355 10 781
Lien Calus 503 564 551 14 761
Shuibin Wang 374 379 463 18 745
Aiko I. Klingler 357 365 414 14 587
Anju Tripathi 324 312 375 18 673
Mingyu Bo 510 567 444 5 775
Dewayne T. Bradley 237 241 433 12 621
Roderick G. Carter 496 435 508 22 831
C Claeys 434 294 462 14 809

All Works

Loading papers...

Rankless by CCL
2026